These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9750358)

  • 1. Pore-forming bacterial cytolysins.
    Bhakdi S; Valeva A; Walev I; Zitzer A; Palmer M
    Symp Ser Soc Appl Microbiol; 1998; 27():15S-25S. PubMed ID: 9750358
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane damage by pore-forming bacterial cytolysins.
    Bhakdi S; Tranum-Jensen J
    Microb Pathog; 1986 Feb; 1(1):5-14. PubMed ID: 2854594
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the damage to membranes caused by bacterial cytolysins.
    Sekiya K; Futaesaku Y
    J Electron Microsc (Tokyo); 1998; 47(6):543-52. PubMed ID: 9972544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friend or foe: the same fold for attack and defense.
    Lukoyanova N; Saibil HR
    Trends Immunol; 2008 Feb; 29(2):51-3. PubMed ID: 18248850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.
    Tweten RK
    Infect Immun; 2005 Oct; 73(10):6199-209. PubMed ID: 16177291
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiol-activated cytolysins: structure, function and role in pathogenesis.
    Billington SJ; Jost BH; Songer JG
    FEMS Microbiol Lett; 2000 Jan; 182(2):197-205. PubMed ID: 10620666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than a pore: the cellular response to cholesterol-dependent cytolysins.
    Cassidy SK; O'Riordan MX
    Toxins (Basel); 2013 Apr; 5(4):618-36. PubMed ID: 23584137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pore formation: an ancient yet complex form of attack.
    Iacovache I; van der Goot FG; Pernot L
    Biochim Biophys Acta; 2008; 1778(7-8):1611-23. PubMed ID: 18298943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell injury and death caused by bacterial protein toxins.
    Donelli G; Fiorentini C
    Toxicol Lett; 1992 Dec; 64-65 Spec No():695-9. PubMed ID: 1471224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between RTX toxins and target cells.
    Lally ET; Hill RB; Kieba IR; Korostoff J
    Trends Microbiol; 1999 Sep; 7(9):356-61. PubMed ID: 10470043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pore-forming cytolysins of gram-negative bacteria.
    Welch RA
    Mol Microbiol; 1991 Mar; 5(3):521-8. PubMed ID: 2046545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular features of the cytolytic pore-forming bacterial protein toxins.
    Alouf JE
    Folia Microbiol (Praha); 2003; 48(1):5-16. PubMed ID: 12744072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sea anemone cytolysins as toxic components of immunotoxins.
    Tejuca M; Anderluh G; Dalla Serra M
    Toxicon; 2009 Dec; 54(8):1206-14. PubMed ID: 19268683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins.
    Bhakdi S; Bayley H; Valeva A; Walev I; Walker B; Kehoe M; Palmer M
    Arch Microbiol; 1996 Feb; 165(2):73-9. PubMed ID: 8593102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular target for Helicobacter pylori vacuolating toxin.
    Cover TL
    Trends Microbiol; 1998 Apr; 6(4):127-8; discussion 128-9. PubMed ID: 9587185
    [No Abstract]   [Full Text] [Related]  

  • 16. The family of thiol-activated, cholesterol-binding cytolysins.
    Palmer M
    Toxicon; 2001 Nov; 39(11):1681-9. PubMed ID: 11595631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanobacteria secondary metabolites--the cyanotoxins.
    Carmichael WW
    J Appl Bacteriol; 1992 Jun; 72(6):445-59. PubMed ID: 1644701
    [No Abstract]   [Full Text] [Related]  

  • 18. Glutamine supports the protection of tissue cells against the damage caused by cholesterol-dependent cytolysins from pathogenic bacteria.
    Turner ML; Owens SE; Sheldon IM
    PLoS One; 2020; 15(3):e0219275. PubMed ID: 32163417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lytic effects of Actinobacillus actinomycetemcomitans leukotoxin on human neutrophil cytoplasts.
    Iwase M; Korchak HM; Lally ET; Berthold P; Taichman NS
    J Leukoc Biol; 1992 Aug; 52(2):224-7. PubMed ID: 1506779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor.
    Ohkuni H; Nagamune H; Ozaki N; Tabata A; Todome Y; Watanabe Y; Takahashi H; Ohkura K; Kourai H; Ohtsuka H; Fischetti VA; Zabriskie JB
    APMIS; 2012 Jan; 120(1):56-71. PubMed ID: 22151309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.